Article | February 8, 2018

Business and Cultural Considerations When Managing Clinical Supplies for Asia-Pacific Studies

Source: Catalent

By Michele Stokes, Vice President of Asia-Pacific Region, Catalent Pharma Solutions

Business and Cultural Considerations When Managing Clinical Supplies for Asia-Pacific Studies

Successfully navigating the rich and diverse Asia-Pacific business and cultural environment can prove tricky for Western study sponsors with limited experience in this region. Although geographically clustered, the more than 40 countries located within the region can vary significantly in terms of language spoken and business practices. Study sponsors should understand and be sensitive to the cultural and business norms of each country included in their study. This approach is vital for anticipating and avoiding costly clinical supply issues or delays, despite careful adherence with all applicable regulatory and Customs requirements.